IRIS
ORIO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.828
EU - Europa 11.474
AS - Asia 6.201
SA - Sud America 961
Continente sconosciuto - Info sul continente non disponibili 492
AF - Africa 80
OC - Oceania 25
Totale 44.061
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.622
RU - Federazione Russa 3.469
UA - Ucraina 2.806
VN - Vietnam 1.840
CN - Cina 1.827
SG - Singapore 1.802
GB - Regno Unito 1.210
SE - Svezia 1.115
DE - Germania 1.027
BR - Brasile 755
FR - Francia 601
IT - Italia 519
FI - Finlandia 342
KR - Corea 129
PL - Polonia 121
CA - Canada 106
IN - India 104
HK - Hong Kong 86
BD - Bangladesh 79
EU - Europa 62
AR - Argentina 61
IQ - Iraq 59
NL - Olanda 43
VE - Venezuela 37
JP - Giappone 36
CO - Colombia 35
TR - Turchia 35
MX - Messico 30
SA - Arabia Saudita 29
BE - Belgio 28
PK - Pakistan 28
EC - Ecuador 26
AT - Austria 24
LV - Lettonia 24
ES - Italia 23
UZ - Uzbekistan 22
ZA - Sudafrica 21
AU - Australia 19
IE - Irlanda 19
PH - Filippine 19
ID - Indonesia 17
MA - Marocco 15
CR - Costa Rica 13
JM - Giamaica 13
TN - Tunisia 12
CL - Cile 11
DK - Danimarca 11
PY - Paraguay 11
PE - Perù 10
PT - Portogallo 10
BG - Bulgaria 9
CZ - Repubblica Ceca 9
IL - Israele 9
BO - Bolivia 8
JO - Giordania 8
KE - Kenya 8
MY - Malesia 8
AZ - Azerbaigian 7
HU - Ungheria 7
AE - Emirati Arabi Uniti 6
BY - Bielorussia 6
EG - Egitto 6
HR - Croazia 6
LT - Lituania 6
OM - Oman 6
PA - Panama 6
RS - Serbia 6
AL - Albania 5
BH - Bahrain 5
EE - Estonia 5
HN - Honduras 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
TT - Trinidad e Tobago 5
HT - Haiti 4
KG - Kirghizistan 4
RO - Romania 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
DO - Repubblica Dominicana 3
ET - Etiopia 3
GT - Guatemala 3
KW - Kuwait 3
LU - Lussemburgo 3
MM - Myanmar 3
NI - Nicaragua 3
NO - Norvegia 3
NP - Nepal 3
SV - El Salvador 3
TW - Taiwan 3
AO - Angola 2
BB - Barbados 2
BN - Brunei Darussalam 2
CY - Cipro 2
DZ - Algeria 2
GD - Grenada 2
GR - Grecia 2
IM - Isola di Man 2
IR - Iran 2
LB - Libano 2
Totale 43.592
Salva come PNG Salva come JPEG
Città #
Fairfield 2.739
Woodbridge 2.587
Houston 1.978
Ashburn 1.895
Dong Ket 1.474
Ann Arbor 1.448
Chandler 1.364
Wilmington 1.317
San Jose 1.270
Seattle 1.088
Dallas 1.017
Cambridge 933
Dearborn 890
Jacksonville 780
Singapore 670
Southend 630
Nyköping 614
Boardman 475
Moscow 428
Beijing 379
Council Bluffs 289
Princeton 270
Lawrence 258
The Dalles 208
Ogden 178
Düsseldorf 137
Los Angeles 129
Shanghai 127
Ho Chi Minh City 124
Des Moines 115
Phoenix 115
Kraków 108
Hanoi 94
Yubileyny 90
San Diego 89
Hutchinson 88
São Paulo 87
Helsinki 82
Bremen 75
Hong Kong 75
New York 73
Santa Clara 69
Grafing 66
Nanjing 62
Jinan 55
London 55
Chicago 49
Hefei 40
Englewood 38
Tokyo 34
Frankfurt am Main 33
Brooklyn 32
Edinburgh 28
Norwalk 28
Rome 28
Brussels 27
Shenyang 27
Amsterdam 26
Kunming 24
Munich 24
Riga 24
San Mateo 24
Toronto 24
Baghdad 23
Da Nang 23
Montreal 23
Guangzhou 22
Naples 21
Napoli 21
Nanchang 20
Rio de Janeiro 20
Belo Horizonte 19
Tashkent 19
Atlanta 18
Auburn Hills 18
Milan 18
Chennai 17
Hanover 17
Zhengzhou 17
Boston 16
Mirabella Eclano 16
Taiyuan 16
Buffalo 15
Charlotte 15
Hangzhou 15
Curitiba 14
Dublin 14
Kilburn 14
Lake Worth 14
Vienna 14
Hebei 13
Riyadh 13
Tianjin 13
Brasília 12
Changsha 12
Columbus 12
Falls Church 12
Saint Petersburg 12
Caracas 11
Hounslow 11
Totale 28.204
Salva come PNG Salva come JPEG
Nome #
Il microinfusore: quali indicazioni e quando iniziare 474
Sussidio didattico per gli studenti di igiene generale e applicata per il corso di laurea in scienze del servizio sociale 336
Abnormal heart rate recovery after maximal cardiopulmonary exercise stress testing in young overweight women with polycystic ovary syndrome. 310
Berberine improves reproductive features in obese Caucasian women with polycystic ovary syndrome independently of changes of insulin sensitivity 276
Effects of physical exercise on the female reproductive system. 262
The good and bad effects of statins on insulin sensitivity and secretion 256
Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: a case of idiopathic hirsutism? 252
High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases. 250
A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination. 250
Cardiopulmonary impairment in young women with polycystic ovary syndrome. 245
Secrezioni ormonali ectopiche 243
Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance 242
Gonadal status in reproductive age women after haematopoietic stem cell transplantation for haematological malignancies. 239
Endocrine secretions under abnormal light-dark cycles and in the blind. 233
A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects. 232
The Risk of a Persistent Glucose Metabolism Impairment After Gestational Diabetes Mellitus Is Increased in Patients With Polycystic Ovary Syndrome 230
Cardiological aspects of growth hormone and insulin-like growth factor-I. 229
Current Insights Into Inositol Isoforms, Mediterranean and Ketogenic Diets for Polycystic Ovary Syndrome: From Bench to Bedside. 229
Vitamin D and thyroid disease: to D or not to D? 227
Liver-spleen axis, Insulin-like Growth Factor-(IGF)-I axis and fat mass in overweight/obese females 222
Failure of long-term therapy with sodium valproate in Cushing's disease. 219
Adiponectin levels in women with polycystic ovary syndrome 219
Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trial. 217
Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response 216
Height, weight, height velocity of primary school population sample in Campania region. 215
Effects of neridronate treatment in elderly women with osteoporosis 214
Bisphenol A in Polycystic Ovary Syndrome and its Association with Liver-Spleen Axis. 214
THE IMPACT OF PROBAND GLUCOSE TOLERANCE STATUS ON BODY MASS INDEX (BMI) AND ADIPOSITY IN ADOLESCENT GIRLS AT HIGH RISK FOR POLYCYSTIC OVARY SYNDROME (PCOS) 212
The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study 212
Lifestyle changes in the management of adulthood and childhood obesity. 212
Adrenal mass: insight into pathogenesis and a common link with insulin resistance. 212
Ovulation induction in polycystic ovary syndrome 211
Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome 211
Gonadotropin-releasing hormone agonist with or without raloxifene: effects on cognition, mood and quality of life 210
Early carotid atherosclerosis in normotensive severe obese premenopausal women with low DHEA(S). 210
Low 25 (OH) vitamin D levels are associated with autoimmune thyroid disease in polycystic ovary syndrome 209
Human prostatic cell line PNT1A, a useful tool for studying androgen receptor transcriptional activity and its differential subnuclear localization in the presence of androgens and antiandrogens. 208
Growth rate and growth hormone response to growth hormone-releasing hormone challenge in slowly growing children during chronic administration of clonidine. 206
Hypothalamic-pituitary-gonadal axis function after successful kidney transplantation in men and women 206
Are serum adiponectin levels really reduced in obese women with polycystic ovary syndrome? 206
Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial. 205
How to manage the reproductive issues of PCOS: a 2015 integrated endocrinological and gynecological consensus statement of the Italian Society of Endocrinology. 205
Effect of growth hormone on cardiac function. 204
Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. 204
The impact of vitamin D deficiency on patients undergoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes. 204
Auditory brainstem responses in thyroid diseases before and after therapy. 203
Report on the Third Annual Meeting of the Androgen Excess Society, San Diego, California, June 3, 2005 203
Serum 25-Hydroxyvitamin D Levels, phosphoprotein enriched in diabetes gene product (PED/PEA-15) and leptin-to-adiponectin ratio in women with PCOS 203
Is the ovulation induction still a therapeutic problem in patients with polycystic ovary syndrome? 202
The increase of leukocytes as a new putative marker of low- grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome 202
Visceral fat and cardiovascular risk in patients with polycystic ovary syndrome. 202
Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review 202
Effect of estrogen replacement plus low-dose alendronate treatment on bone density in surgically postmenopausal women with osteoporosis. 201
Growth hormone secretion after baclofen administration in different phases of menstrual cycle in healthy women. 201
Thyroid function and morphology after a successful kidney transplantation 200
Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin 200
Raloxifene administration in women treated with gonadotropin-releasing hormone agonist for uterine leiomyomas: effects on bone metabolism. 200
Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies. 200
Could the Mediterranean diet be effective in women with polycystic ovary syndrome? A proof of concept. 200
Adrenocortical tumors and insulin resistance. What is the first step? 200
Growth hormone secretion after baclofen administration in different phases of menstrual cycle in healthy women 199
Metformin administration and laparoscopic ovarian drilling improve ovarian response to clomiphene citrate (CC) in oligo-anovulatory CC-resistant women with polycystic ovary syndrome 199
Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome 199
Laparoscopic ovarian diathermy vs clomiphene citrate plus metformin as second-line strategy for infertile anovulatory patients with polycystic ovary syndrome: a randomized controlled trial 198
Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome. 198
Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial 198
Growth hormone status in morbidly obese subjects and correlation with body composition 197
Screening a coastal population in Southern Italy: iodine deficiency and prevalence of goitre, nutritional aspects and cardiovascular risk factors 197
Endothelial dysfunction in PCOS: role of obesity and adipose hormones. 196
Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes. 195
Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome 194
Role of dehydroepiandrosterone sulfate levels on body composition after laparoscopic adjustable gastric banding in pre-menopausal morbidly obese women 194
Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials 194
Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells. 194
Cardiovascular risk of women with polycystic ovary syndrome 194
Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome 194
Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review 194
Does raloxifene inhibit the growth of uterine fibroids? 193
Anti-proliferative and pro-apoptotic effects of raloxifene on uterine leiomyomas in postmenopausal women 193
Antisperm antibodies in cryptorchidism before and after surgery. 193
Efficacy of laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: relationships with chronological and ovarian age 192
Relationship between growth hormone/insulin-like growth factor-1 axis integrity and voluntary weight loss after gastric banding surgery for severe obesity. 192
Circulating ghrelin concentrations in the polycystic ovary syndrome 192
Leuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndrome 192
Terapia di associazione con insulina ed analoghi del GLP-1 192
Current evidence on vitamin D deficiency and kidney transplant: What’s new? 192
Evidence for altered adipocyte function in polycystic ovary syndrome. 190
Growth hormone treatment prevents loss of lean mass after bariatric surgery in morbidly obese patients: results of a pilot, open, prospective, randomized, controlled study 190
Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? 190
Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease 190
Uterine effects of clomiphene citrate in women with polycystic ovary syndrome: a prospective controlled study 189
GH and IGF-I deficiency are associated with reduced loss of fat mass after laparoscopic-adjustable silicone gastric banding. 189
Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome:A Prospective Parallel Randomized Double-Blind Placebo-Controlled Trial 189
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome 189
Clomiphene citrate, metformin or both as first-step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head-to-head randomized controlled studies and meta-analysis 188
Pervasive developmental disorders in children of hyperandrogenic women with polycystic ovary syndrome: a longitudinal case-control study. 187
Clinical use of the perifollicular vascularity assessment in IVF cycles: a pilot study 187
Pretreatment with oral contraceptives in infertile anovulatory patients with polycystic ovary syndrome who receive gonadotropins for controlled ovarian stimulation. 186
Six weeks of structured exercise training and hypocaloric diet increases the probability of ovulation after clomiphene citrate in overweight and obese patients with polycystic ovary syndrome: a randomized controlled trial 186
Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study 186
Totale 21.218
Salva come PNG Salva come JPEG
Categoria #
all - tutte 175.513
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 175.513
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.676 0 0 0 771 76 45 253 199 141 116 69 6
2022/20234.290 523 136 215 458 498 796 115 566 571 120 223 69
2023/20241.231 134 71 77 54 54 34 25 316 268 56 12 130
2024/20255.948 86 505 15 133 86 499 1.693 2.000 322 199 205 205
2025/20266.434 491 820 523 413 413 163 988 645 948 710 173 147
2026/20271.819 127 131 808 753 0 0 0 0 0 0 0 0
Totale 44.061